Course of D-Dimer and C-Reactive Protein Levels in Survivors and Nonsurvivors with COVID-19 Pneumonia: A Retrospective Analysis of 577 Patients

Luca Valerio; Paola Ferrazzi; Clara Sacco; Wolfram Ruf; Nils Kucher; Stavros V. Konstantinides; Stefano Barco; Corrado Lodigiani; On behalf of Humanitas COVID-19 Task Force

doi:10.1055/s-0040-1721317

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2021; 121(01): 098-101
DOI: 10.1055/s-0040-1721317

Letter to the Editor

Course of D-Dimer and C-Reactive Protein Levels in Survivors and Nonsurvivors with COVID-19 Pneumonia: A Retrospective Analysis of 577 Patients

Luca Valerio

¹Center for Thrombosis and Hemostasis, University Medical Center, University of Mainz, Mainz, Germany

,

Paola Ferrazzi

²Center for Thrombosis and Hemorrhagic Diseases, Humanitas Clinical and Research Center—IRCCS, Rozzano, Milan, Italy

,

Clara Sacco

²Center for Thrombosis and Hemorrhagic Diseases, Humanitas Clinical and Research Center—IRCCS, Rozzano, Milan, Italy

,

Wolfram Ruf

¹Center for Thrombosis and Hemostasis, University Medical Center, University of Mainz, Mainz, Germany

,

Nils Kucher

³Clinic of Angiology, University Hospital Zurich, Zurich, Switzerland

,

Stavros V. Konstantinides

¹Center for Thrombosis and Hemostasis, University Medical Center, University of Mainz, Mainz, Germany

⁴Department of Cardiology, Democritus University of Thrace, Alexandroupolis, Greece

,

Stefano Barco

¹Center for Thrombosis and Hemostasis, University Medical Center, University of Mainz, Mainz, Germany

³Clinic of Angiology, University Hospital Zurich, Zurich, Switzerland

,

Corrado Lodigiani

²Center for Thrombosis and Hemorrhagic Diseases, Humanitas Clinical and Research Center—IRCCS, Rozzano, Milan, Italy

,

On behalf of Humanitas COVID-19 Task Force

› Author Affiliations

Abstract

Full Text

References

References
1 Zhou F, Yu T, Du R. et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020; 395 (10229): 1054-1062
2 Bikdeli B, Madhavan MV, Gupta A. et al. Global COVID-19 Thrombosis Collaborative Group. Pharmacological agents targeting thromboinflammation in COVID-19: review and implications for future research. Thromb Haemost 2020; 120 (07) 1004-1024
3 Marchandot B, Trimaille A, Curtiaud A. et al. Staging severity of COVID-19 according to hemostatic abnormalities (CAHA Score). Thromb Haemost 2020; 120 (12) 1716-1719
4 Wynants L, Van Calster B, Collins GS. et al. Prediction models for diagnosis and prognosis of covid-19 infection: systematic review and critical appraisal. BMJ 2020; 369: m1328
5 Li Y, Zhao K, Wei H. et al. Dynamic relationship between D-dimer and COVID-19 severity. Br J Haematol 2020; 190 (01) e24-e27
6 Ye W, Chen G, Li X. et al. Dynamic changes of D-dimer and neutrophil-lymphocyte count ratio as prognostic biomarkers in COVID-19. Respir Res 2020; 21 (01) 169
7 Lodigiani C, Iapichino G, Carenzo L. et al. Humanitas COVID-19 Task Force. Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy. Thromb Res 2020; 191: 9-14
8 Zhai Z, Li C, Chen Y. et al. Prevention Treatment of VTE Associated with COVID-19 Infection Consensus Statement Group. Prevention and treatment of venous thromboembolism associated with coronavirus disease 2019 infection: a consensus statement before guidelines. Thromb Haemost 2020; 120 (06) 937-948
9 Hornung RW, Reed LD. Estimation of average concentration in the presence of nondetectable values. Appl Occup Environ Hyg 1990; 5 (01) 46-51
10 Katneni UK, Alexaki A, Hunt RC. et al. Coagulopathy and thrombosis as a result of severe COVID-19 infection: a microvascular focus. Thromb Haemost 2020; 120 (12) 1668-1679
11 Roncon L, Zuin M, Barco S. et al. Incidence of acute pulmonary embolism in COVID-19 patients: systematic review and meta-analysis. Eur J Intern Med 2020; 82: 29-37
12 Eriksson O, Hultstrom M, Persson B. et al. Mannose-binding lectin is associated with thrombosis and coagulopathy in critically ill COVID-19 patients. Thromb Haemost 2020; 120 (12) 1720-1724
13 Onishi T, Nogami K, Ishihara T. et al. A pathological clarification of sepsis-associated disseminated intravascular coagulation based on comprehensive coagulation and fibrinolysis function. Thromb Haemost 2020; 120 (09) 1257-1269
14 Spiezia L, Boscolo A, Poletto F. et al. COVID-19-related severe hypercoagulability in patients admitted to intensive care unit for acute respiratory failure. Thromb Haemost 2020; 120 (06) 998-1000
15 Posch F, Riedl J, Reitter E-M. et al. Dynamic assessment of venous thromboembolism risk in patients with cancer by longitudinal D-dimer analysis: a prospective study. J Thromb Haemost 2020; 18 (06) 1348-1356
16 Legnani C, Palareti G, Cosmi B, Cini M, Tosetto A, Tripodi A. PROLONG Investigators (FCSA and Italian Federation of Thrombosis Centers). Different cut-off values of quantitative D-dimer methods to predict the risk of venous thromboembolism recurrence: a post-hoc analysis of the PROLONG study. Haematologica 2008; 93 (06) 900-907
17 Collins GS, van Smeden M, Riley RD. COVID-19 prediction models should adhere to methodological and reporting standards. Eur Resp J 2020; 56 (03) 2002643
18 Barco S, Mahmoudpour SH, Valerio L. et al. Trends in mortality related to pulmonary embolism in the European Region, 2000-15: analysis of vital registration data from the WHO Mortality Database. Lancet Respir Med 2020; 8 (03) 277-287
19 Barco S, Valerio L, Ageno W. et al. Age-sex specific pulmonary embolism-related mortality in the USA and Canada, 2000–18: an analysis of the WHO Mortality Database and of the CDC Multiple Cause of Death database. Lancet Respir Med 2020;